Department of Pharmacology, Laboratory of Addictive Disorders, Boston University School of Medicine, 72 E Concord St., R-618, Boston, MA 02118, USA.
Psychopharmacology (Berl). 2013 Mar;226(1):127-38. doi: 10.1007/s00213-012-2898-3. Epub 2012 Oct 27.
Impulsive behavior is categorically differentiated between impulsive action, the inability to withhold from acting out a response, and impulsive choice, the greater preference for an immediate and smaller reward over a delayed but more advantageous reward. While the effects of N-methyl-D-aspartic acid (NMDA) receptor antagonists on impulsive action have been extensively characterized, there are very few and conflicting reports on the effects of this class of drugs on impulsive choice.
Using a modified adjusting delay task, we investigated the effects of uncompetitive and competitive blockade of NMDA receptors on impulsive choice.
Male Wistar rats were trained in a modified adjusting delay task, which involved repeated choice between a low reinforcing solution delivered immediately and a highly reinforcing solution delivered after a variable delay. Rats were then administered either the NMDA receptor uncompetitive antagonists ketamine or memantine, or the competitive antagonists D-AP-5 or CGS 19755.
Ketamine treatment dose-dependently increased impulsive choice, and this effect was selective for low-impulsive but not high-impulsive rats. Similarly, memantine treatment dose-dependently increased impulsive choice with a preferential effect for low-impulsive rats. While D-AP-5 treatment did not affect impulsive choice, CGS 19755 increased impulsivity, however, at the same doses at which it caused a marked response inhibition.
NMDA receptor uncompetitive, but not competitive, antagonists significantly increased impulsive choice, preferentially in low-impulsive rats. These findings demonstrate that the effects of NMDA receptor blockade on impulsive choice are not generalizable and depend on the specific mechanism of action of the antagonist used.
冲动行为分为冲动行为和冲动选择,前者是指无法抑制对反应的行动,后者是指对即时较小的奖励的偏好大于对延迟较大的奖励的偏好。虽然 N-甲基-D-天冬氨酸(NMDA)受体拮抗剂对冲动行为的影响已被广泛研究,但关于此类药物对冲动选择影响的报道却很少且相互矛盾。
使用改良的调整延迟任务,我们研究了 NMDA 受体非竞争性和竞争性阻断对冲动选择的影响。
雄性 Wistar 大鼠在改良的调整延迟任务中接受训练,该任务涉及在即时提供的低强化溶液和在可变延迟后提供的高强化溶液之间进行反复选择。然后,大鼠接受 NMDA 受体非竞争性拮抗剂氯胺酮或美金刚,或竞争性拮抗剂 D-AP-5 或 CGS 19755 的治疗。
氯胺酮治疗剂量依赖性地增加了冲动选择,并且这种作用对低冲动大鼠具有选择性,但对高冲动大鼠没有影响。同样,美金刚治疗剂量依赖性地增加了冲动选择,对低冲动大鼠有优先作用。虽然 D-AP-5 治疗不影响冲动选择,但 CGS 19755 增加了冲动性,但在引起明显反应抑制的相同剂量下。
NMDA 受体非竞争性但不是竞争性拮抗剂显著增加了冲动选择,特别是在低冲动大鼠中。这些发现表明,NMDA 受体阻断对冲动选择的影响不是普遍的,取决于所使用的拮抗剂的特定作用机制。